Yi‐Cheng Wu

High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan

Shiu‐Feng Huang, Hui-Ping Liu, Ling-Hui Li et al. · Clinical Cancer Research · 2004 · 553 citations

Medicine, Molecular Biology, Oncology +16

Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer

Chien-Ying Liu, Yumin Wang, Chih-Liang Wang et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 301 citations · Full text

Medicine, Immunology, Oncology +14

Laparoscopic bipolar coagulation of uterine vessels: a new method for treating symptomatic fibroids

Wei‐Min Liu, Heung-Tat Ng, Yi‐Cheng Wu et al. · Fertility and Sterility · 2001 · 119 citations · Full text

Medicine, Gynecology, Surgery +10

Biomarker analyses from a phase III, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) in Asia (IPASS)

M. Fukuoka, Yi‐Cheng Wu, S. Thongprasert et al. · Journal of Clinical Oncology · 2009 · 119 citations

Medicine, Oncology, Pharmacotherapy +13

Comparison of IHC, FISH and RT-PCR Methods for Detection of ALK Rearrangements in 312 Non-Small Cell Lung Cancer Patients in Taiwan

Yi‐Cheng Wu, Il‐Chi Chang, Chi-Liang Wang et al. · PLoS ONE · 2013 · 109 citations · Full text

Medicine, Oncology, Pathology +17